(Media Line-Jerusalem Post) Katte Beiter - Over the past five years, an aggressive campaign predicated upon awareness, identification and research has apparently been responsible for significantly lower skin cancer rates in Israel. "We were third in the world in the incidents and mortality after Australia and New Zealand and it was, of course, because we have a lot of people who come from Europe with light skin," said Miri Ziv, director general of the Israel Cancer Association. "In the last five years, Israel dropped to the 20th country with the highest incidents (of skin cancer) and in terms of mortality, we dropped to number 13 for men and number 20 for women." Emerald Medical Applications has released an FDA-approved free app, DermaCompare, which uses air force image processing and big data analytics to track suspicious moles by asking users to take photos of themselves and upload the images to the app every six months. In addition, in 2014, the FDA approved a revolutionary antibody drug to treat metastatic melanoma, Keytruda, developed jointly by researchers in the U.S. and Israel. Keytruda helps the immune system destroy the tumor and has revolutionized cancer treatment.
2016-08-18 00:00:00Full ArticleBACK Visit the Daily Alert Archive